/Investor DB

Iaso Ventures — 2023 Investments

2 investments dated 2023 · listed companies and verified rows first · show all

Catena Biosciencescatenabio.cominSeed · Mar 2023 · $5M

CatenaBio develops precision conjugation technology using native amino acids to enable biotherapeutic fusions of small molecules, nucleic acids, enzymes, and cells.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

Marco Lobba(Founder)inMatthew Francis(Founder)inGeo Guillen

Co-investorsCalifornia Innovation FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)FREEFLOWGaingelsJude Gomila+14 more

Ryghtryght.aiinSeed · Aug 2023 · $4.3M

Ryght AI provides an artificial intelligence-powered platform that uses digital twin technology to help clinical research organizations and sponsors identify and select optimal sites for clinical trials.

AI & Machine LearningBiotechHealthtechMedical Devices

Dr. Chadi Nabhan(Chief Medical Officer)Tom Pike(President and Chief Executive Officer)

Co-investorsAIX VenturesFoothill VenturesPage One VenturesVirtue VenturesLDV PartnersTop Harvest Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.